Recently there has been an increase in the prostatitis treatment market, especially in the United States and Canada. The reason behind the surge appears to be growth in extensive research and development in this area of prostate health. More prostatitis treatment options and advances are coming to market, and this is being met by more…
If you have an enlarged prostate, are getting up multiple times during the night to urinate, and are tired of being tired, then Urolift may be the answer for you. This relatively new procedure can be helpful for men who want an alternative to medications and other medical procedures for this prostate condition. For some…
If you have ever had your prostate-specific antigen (PSA) levels checked, you know the typical drill. A nurse or technician takes a blood sample from a vein in your arm, the sample is sent to a lab for analysis, and then you wait for the results, which takes days. Now a new fingerprick PSA test…
Use of a special form of positron emission tomographic (PET) imaging has proven prostate cancer return (recurrence) can be detected with a high degree of accuracy. The authors of the single-arm prospective trial noted that the new approach allowed them to detect tumors that could be missed by more conventional imaging. Prostate cancer return After…
The new prostate cancer drug darolutamide has been fast tracked by the Food and Drug Administration (FDA), just two months after Bayer and Orion reported positive data from a Phase III trial. Darolutamide is a nonsteroidal androgen receptor inhibitor for men with late-stage prostate cancer that has not spread but continues to grow even though…
A recent study reported on the global decline in prostate cancer diagnoses, which sounds like great news. Indeed, the data from five continents and covering up to 32 years showed that in many areas of the world, prostate cancer diagnoses and deaths had decreased or stabilized. The experts worked with data provided by the following…
